Umeclidinium 62.5mcg, vilanterol 25mcg; per ­inhalation; dry pwd for oral inhalation. Umeclidinium is a long-acting muscarinic antagonist, which is often referred to as an anticholinergic. It has ...

Sales of COPD inhalers Trelegy Ellipta, Breo Ellipta and Anoro Ellipta are likely to have contributed to first-quarter 2024 sales. Our model suggests Trelegy Ellipta, Breo Ellipta and Anoro Ellipt ...

The FDA announced yesterday that is has approved Anoro Ellipta (umeclidinium and vilanterol inhalation powder) for the once-daily, long-term maintenance treatment of airflow obstruction in ...

Sales of its asthma and COPD medication Advair are declining, and payers are demanding more from its next generation treatments Breo and Anoro Ellipta. “Digital innovations, like sensor ...

and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M.